DeDora Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-12,068
| Closed | -$492K | – | 105 |
|
2023
Q1 | $492K | Sell |
12,068
-502
| -4% | -$20.5K | 0.21% | 77 |
|
2022
Q4 | $644K | Buy |
12,570
+6,682
| +113% | +$342K | 0.31% | 69 |
|
2022
Q3 | $258K | Buy |
5,888
+549
| +10% | +$24.1K | 0.13% | 90 |
|
2022
Q2 | $280K | Buy |
5,339
+301
| +6% | +$15.8K | 0.14% | 85 |
|
2022
Q1 | $261K | Sell |
5,038
-53
| -1% | -$2.75K | 0.11% | 86 |
|
2021
Q4 | $301K | Sell |
5,091
-16
| -0.3% | -$946 | 0.17% | 46 |
|
2021
Q3 | $220K | Sell |
5,107
-348
| -6% | -$15K | 0.1% | 93 |
|
2021
Q2 | $214K | Buy |
+5,455
| New | +$214K | 0.09% | 93 |
|
2020
Q4 | – | Sell |
-11,314
| Closed | -$394K | – | 93 |
|
2020
Q3 | $394K | Sell |
11,314
-1,882
| -14% | -$65.5K | 0.22% | 73 |
|
2020
Q2 | $409K | Buy |
13,196
+366
| +3% | +$11.3K | 0.25% | 71 |
|
2020
Q1 | $397K | Sell |
12,830
-149
| -1% | -$4.61K | 0.3% | 64 |
|
2019
Q4 | $482K | Sell |
12,979
-307
| -2% | -$11.4K | 0.29% | 64 |
|
2019
Q3 | $453K | Buy |
13,286
+626
| +5% | +$21.3K | 0.31% | 59 |
|
2019
Q2 | $520K | Buy |
12,660
+324
| +3% | +$13.3K | 0.37% | 56 |
|
2019
Q1 | $497K | Buy |
12,336
+3,570
| +41% | +$144K | 0.37% | 54 |
|
2018
Q4 | $363K | Sell |
8,766
-532
| -6% | -$22K | 0.32% | 58 |
|
2018
Q3 | $389K | Sell |
9,298
-1,141
| -11% | -$47.7K | 0.29% | 58 |
|
2018
Q2 | $359K | Sell |
10,439
-3,301
| -24% | -$114K | 0.28% | 69 |
|
2018
Q1 | $463K | Sell |
13,740
-310
| -2% | -$10.4K | 0.38% | 53 |
|
2017
Q4 | $483K | Buy |
+14,050
| New | +$483K | 0.4% | 49 |
|